Evoke Pharma (EVOK) Misses Q1 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• BMO Capital Downgrades Linamar Corp (LNR:CN) (LIMAF) to Market Perform
• TotalEnergies strikes $1.8B deal with GIP on African assets